Effect of Fluvastatin on Serotonin Transporter Expression in Rats with Pulmonary Arterial Hypertension

朱少平,毛志福,黄杰,王君钰
DOI: https://doi.org/10.3969/j.issn.1673-0070.2009.04.002
2009-01-01
Abstract:Objective To investigate the effect of fluvastatin on serotonin transporter expression in rats with pulmonary arterial hypertension.Methods 62 rats were randomly divided into 3 groups.One group(M+F,n=26) received 2-week subcutaneous injection of MCT(40 mg/kg,qd) with a continuous administration of fluvastatin(1 mg/kg) once a day by gavage for 6 weeks.Another group(MCT,n=26) received a single subcutaneous injection of MCT(40 mg/kg) in the first 2 weeks,and then were given an equivalent volume of saline gavage from 15th day to 42nd day.The third group(Saline,n=10) received a 2-week equivalent volume of 0.9% saline injection and a 4-week saline gavage,respectively.Pulmonary arterial pressure(PAP) and serotonin transporter(5-HTT) protein expressions were detected at various time during the 6-week observation.Results Rats in MCT group presented with dramatic PAH together with overexpression of 5-HTT protein at 14th day,which went further in the observation;however,only mild PAH was observed in M+F group without upregulation of 5-HTT protein at 42nd day.Conclusion Fluvastatin can effectively inhibit overexpression of 5-HTT protein in MCT-induced hypertension,it could possibly correlate with the preventive effect of fluvastatin on rats with pulmonary arterial hypertension.
What problem does this paper attempt to address?